Abbott Completes Acquisition of Bigfoot Biomedical
(Source: Abbott.com)
Source: Abbott.com - September 22, 2023 Category: Pharmaceuticals Source Type: news
Abbott Declares 399th Consecutive Quarterly Dividend
(Source: Abbott.com)
Source: Abbott.com - September 21, 2023 Category: Pharmaceuticals Source Type: news
Abbott Broadens Access to Cutting-Edge Biosimilars in Key Emerging Markets
(Source: Abbott.com)
Source: Abbott.com - September 20, 2023 Category: Pharmaceuticals Source Type: news
Abbott and WeightWatchers Connected App Experience is Now Available for People Living with Diabetes
(Source: Abbott.com)
Source: Abbott.com - September 19, 2023 Category: Pharmaceuticals Source Type: news
Abbott to Acquire Bigfoot Biomedical, Furthering Efforts to Develop Personalized, Connected Solutions for People with Diabetes
(Source: Abbott.com)
Source: Abbott.com - September 5, 2023 Category: Pharmaceuticals Source Type: news
Abbott Unveils Late-Breaking Data Showing Intravascular Imaging via OCT Can Improve Stent Procedural Outcomes, Especially in Complex Cases
• Data from the landmark ILUMIEN IV trial, the first randomized imaging trial with global representation, has the potential to change clinical practice related to stent placement (Source: Abbott.com)
Source: Abbott.com - August 27, 2023 Category: Pharmaceuticals Source Type: news
FDA Clears Abbott ’s Alinity h-series Lab Instruments, Enabling Advanced Testing of Patients’ Complete Blood Counts
(Source: Abbott.com)
Source: Abbott.com - August 7, 2023 Category: Pharmaceuticals Source Type: news
Abbott Reports Second-Quarter 2023 Results; Increases Outlook For Underlying Base Business
(Source: Abbott.com)
Source: Abbott.com - July 20, 2023 Category: Pharmaceuticals Source Type: news
Abbott Receives FDA Approval for World's First Dual Chamber Leadless Pacemaker
(Source: Abbott.com)
Source: Abbott.com - July 5, 2023 Category: Pharmaceuticals Source Type: news
Abbott Hosts Conference Call for Second-Quarter Earnings
(Source: Abbott.com)
Source: Abbott.com - June 29, 2023 Category: Pharmaceuticals Source Type: news
The American Diabetes Association and Abbott Collaborate on First-of-Its-Kind Therapeutic Nutrition Program for People with Diabetes
(Source: Abbott.com)
Source: Abbott.com - June 24, 2023 Category: Pharmaceuticals Source Type: news
Abbott's FreeStyle Libre ® 2 Receives National Reimbursement in France for All People with Diabetes Who Use Insulin¹
(Source: Abbott.com)
Source: Abbott.com - June 22, 2023 Category: Pharmaceuticals Source Type: news
Abbott Declares 398th Consecutive Quarterly Dividend
(Source: Abbott.com)
Source: Abbott.com - June 9, 2023 Category: Pharmaceuticals Source Type: news
Abbott, Real Madrid and the Real Madrid Foundation Band Together to 'Beat Malnutrition' Globally Through New Campaign
(Source: Abbott.com)
Source: Abbott.com - May 31, 2023 Category: Pharmaceuticals Source Type: news
European Study Finds the Abbott CardioMEMS Sensor Results in Improved Quality of Life and 44% Reduction in Heart Failure Hospitalizations
(Source: Abbott.com)
Source: Abbott.com - May 24, 2023 Category: Pharmaceuticals Source Type: news
